Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Barton

Showing results (161-170 of 296) with videos related to

Pageof 30
Sort By:
Rheumatology (Oxford, England)|October 3, 2022
Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritisRyan M Hum, Pauline Ho, Nisha Nair, et al.
The Journal of Investigative Dermatology|November 13, 2013
Polymorphisms in IL-1B distinguish between psoriasis of early and late onsetHarry L Hébert, John Bowes, Rhodri L Smith, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 9, 2016
HLA-DRB1 Amino Acid Positions 11/13, 71, and 74 Are Associated With Inflammation Level, Disease Activity, and the Health Assessment Questionnaire Score in Patients With Inflammatory PolyarthritisStephanie F Ling, Sebastien Viatte, Mark Lunt, et al.
Annals of the Rheumatic Diseases|October 8, 2015
Anticarbamylated protein antibodies are associated with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis RegisterJennifer H Humphreys, Marije K Verheul, Anne Barton, et al.
Pharmacogenetics and Genomics|March 6, 2009
Investigation of genetic variants within candidate genes of the TNFRSF1B signalling pathway on the response to anti-TNF agents in a UK cohort of rheumatoid arthritis patientsJohn D Bowes, Catherine Potter, Laura J Gibbons, et al.
Arthritis and Rheumatism|January 1, 2009
Identification of a novel susceptibility locus for juvenile idiopathic arthritis by genome-wide association analysisAnne Hinks, Anne Barton, Neil Shephard, et al.
Nature Communications|December 1, 2015
Capture Hi-C reveals novel candidate genes and complex long-range interactions with related autoimmune risk lociPaul Martin, Amanda McGovern, Gisela Orozco, et al.
Pharmacogenomics|October 30, 2020
Pharmacogenetics of TNF inhibitor response in rheumatoid arthritis utilizing the two-component disease activity scoreSyed Sa Gilani, Nisha Nair, Darren Plant, et al.
RMD Open|January 27, 2017
Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RAMeghna Jani, William G Dixon, Lianne Kersley-Fleet, et al.
Annals of the Rheumatic Diseases|August 2, 2011
Investigation of IL1, VEGF, PPARG and MEFV genes in psoriatic arthritis susceptibilityJohn Bowes, Pauline Ho, Edward Flynn, et al.
Pageof 30

Showing results (161-170 of 296) with videos related to

Sort By:
Pageof 30
Rheumatology (Oxford, England)|October 3, 2022
Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritisRyan M Hum, Pauline Ho, Nisha Nair, et al.
The Journal of Investigative Dermatology|November 13, 2013
Polymorphisms in IL-1B distinguish between psoriasis of early and late onsetHarry L Hébert, John Bowes, Rhodri L Smith, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 9, 2016
HLA-DRB1 Amino Acid Positions 11/13, 71, and 74 Are Associated With Inflammation Level, Disease Activity, and the Health Assessment Questionnaire Score in Patients With Inflammatory PolyarthritisStephanie F Ling, Sebastien Viatte, Mark Lunt, et al.
Annals of the Rheumatic Diseases|October 8, 2015
Anticarbamylated protein antibodies are associated with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis RegisterJennifer H Humphreys, Marije K Verheul, Anne Barton, et al.
Pharmacogenetics and Genomics|March 6, 2009
Investigation of genetic variants within candidate genes of the TNFRSF1B signalling pathway on the response to anti-TNF agents in a UK cohort of rheumatoid arthritis patientsJohn D Bowes, Catherine Potter, Laura J Gibbons, et al.
Arthritis and Rheumatism|January 1, 2009
Identification of a novel susceptibility locus for juvenile idiopathic arthritis by genome-wide association analysisAnne Hinks, Anne Barton, Neil Shephard, et al.
Nature Communications|December 1, 2015
Capture Hi-C reveals novel candidate genes and complex long-range interactions with related autoimmune risk lociPaul Martin, Amanda McGovern, Gisela Orozco, et al.
Pharmacogenomics|October 30, 2020
Pharmacogenetics of TNF inhibitor response in rheumatoid arthritis utilizing the two-component disease activity scoreSyed Sa Gilani, Nisha Nair, Darren Plant, et al.
RMD Open|January 27, 2017
Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RAMeghna Jani, William G Dixon, Lianne Kersley-Fleet, et al.
Annals of the Rheumatic Diseases|August 2, 2011
Investigation of IL1, VEGF, PPARG and MEFV genes in psoriatic arthritis susceptibilityJohn Bowes, Pauline Ho, Edward Flynn, et al.
Pageof 30